BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Linfield DT, Raduka A, Aghapour M, Rezaee F. Airway tight junctions as targets of viral infections. Tissue Barriers 2021;9:1883965. [PMID: 33632074 DOI: 10.1080/21688370.2021.1883965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Q, Friedman PA. Receptor-Loaded Virion Endangers GPCR Signaling: Mechanistic Exploration of SARS-CoV-2 Infections and Pharmacological Implications. Int J Mol Sci 2021;22:10963. [PMID: 34681624 DOI: 10.3390/ijms222010963] [Reference Citation Analysis]
2 Uddin MA, Akhter MS, Kubra KT, Barabutis N. Induction of the NEK family of kinases in the lungs of mice subjected to cecal ligation and puncture model of sepsis. Tissue Barriers 2021;9:1929787. [PMID: 34151722 DOI: 10.1080/21688370.2021.1929787] [Reference Citation Analysis]
3 Godbole NM, Chowdhury AA, Chataut N, Awasthi S. Tight Junctions, the Epithelial Barrier, and Toll-like Receptor-4 During Lung Injury. Inflammation 2022. [PMID: 35779195 DOI: 10.1007/s10753-022-01708-y] [Reference Citation Analysis]
4 Shirvaliloo M. The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung. Tissue Barriers 2021;:1937013. [PMID: 34232823 DOI: 10.1080/21688370.2021.1937013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Liu W, Tang D, Xu XX, Liu YJ, Jiu Y. How Physical Factors Coordinate Virus Infection: A Perspective From Mechanobiology. Front Bioeng Biotechnol 2021;9:764516. [PMID: 34778236 DOI: 10.3389/fbioe.2021.764516] [Reference Citation Analysis]
6 Oliva J, Terrier O. Viral and Bacterial Co-Infections in the Lungs: Dangerous Liaisons. Viruses 2021;13:1725. [PMID: 34578306 DOI: 10.3390/v13091725] [Reference Citation Analysis]
7 Ashour L. Roles of the ACE/Ang II/AT1R pathway, cytokine release, and alteration of tight junctions in COVID-19 pathogenesis. Tissue Barriers 2022;:2090792. [PMID: 35726726 DOI: 10.1080/21688370.2022.2090792] [Reference Citation Analysis]
8 Lenárt S, Lenárt P, Knopfová L, Kotasová H, Pelková V, Sedláková V, Vacek O, Pokludová J, Čan V, Šmarda J, Souček K, Hampl A, Beneš P. TACSTD2 upregulation is an early reaction to lung infection. Sci Rep 2022;12:9583. [PMID: 35688908 DOI: 10.1038/s41598-022-13637-9] [Reference Citation Analysis]
9 Finotto S, Jartti T, Johnston SL. Editorial: Type I and Type III Interferon Immune Responses in Asthma. Front Immunol 2022;12:826363. [DOI: 10.3389/fimmu.2021.826363] [Reference Citation Analysis]
10 Huang H, Li Y, Wang L, Song Y, Zhang G. Membrane proteomic analysis identifies the polarity protein PARD3 as a novel antiviral protein against PEDV infection. J Proteomics 2021;:104462. [PMID: 34954106 DOI: 10.1016/j.jprot.2021.104462] [Reference Citation Analysis]
11 Adil MS, Khulood D, Narayanan SP, Somanath PR. Bioinformatics analyses reveal cell-barrier junction modulations in lung epithelial cells on SARS-CoV-2 infection. Tissue Barriers 2021;:2000300. [PMID: 34740309 DOI: 10.1080/21688370.2021.2000300] [Reference Citation Analysis]